Search
for
Sort by
Research 901–930 of 1000+
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- A newly discovered linkage between proteoglycans and hair biology: decorin acts as an anagen inducer
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- The clock gene brain and muscle Arnt-like protein-1 (BMAL1) is involved in hair growth
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Insights into Male Androgenetic Alopecia: Differential Gene Expression Profiling of Plucked Hair Follicles and Integration with Genetic Data
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa
- Molecular docking studies and ADME-Tox prediction of phytocompounds from Merremia peltata as a potential anti-alopecia treatment
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility
- The Postnatal Offspring of Finasteride-Treated Male Rats Shows Hyperglycaemia, Elevated Hepatic Glycogen Storage and Altered GLUT2, IR, and AR Expression in the Liver
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
- Plants as potential active components in treatment of androgenetic alopecia
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Effects of Testosterone on the Expression of Connexin 26 and Connexin 43 in the Uterus of Rats During Early Pregnancy
- Pathomechanism of androgenetic alopecia and new treatment
- Clascoterone as a novel treatment for androgenetic alopecia
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Is the “Comb Over” Dying? A Mouse Model for Male Pattern Baldness (Androgenic Alopecia)
- Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia